Bayer, Besins Healthcare add new drugs

The TGA has approved Bayer’s macrocyclic gadolinium-based contrast agent Ambelvist and Besins Healthcare’s progestogen-only oral Slindelle.

To see the whole article, log in or create an account.

Tiffany Walker